Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Mitochondrial Dysfunction in Atrial Fibrillation: Translation to Druggable Target and Biomarker Discovery
Lisa Pool, Leonoor F. J. M. Wijdeveld, Natasja M.S. de Groot, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8463-8463
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Atrial fibrillation
Bianca J.J.M. Brundel, Xun Ai, Mellanie True Hills, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 284
NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation
Roberto Ramos‐Mondragón, Andrey Lozhkin, Aleksandr E. Vendrov, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1833-1833
Open Access | Times Cited: 21
Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders
Marco Miotto, Steve Reiken, Anetta Wronska, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed
Alina M. Bețiu, Lavinia Noveanu, Iasmina M. Hâncu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13653-13653
Open Access | Times Cited: 22
LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation
Matthew B. Murphy, Zhenjiang Yang, Tuerdi Subati, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 8, pp. 899-913
Closed Access | Times Cited: 5
MicroRNAs in Atrial Fibrillation: Mechanisms, Vascular Implications, and Therapeutic Potential
Emmanouil P. Vardas, Panagiotis Theofilis, Evangelos Oikonomou, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 811-811
Open Access | Times Cited: 5
Atrial fibrillation risk model based on LASSO and SVM algorithms and immune infiltration of key mitochondrial energy metabolism genes
Xunjie Yang, Wanwen Lan, Chun-Yi Lin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Evaluating inflammatory status to predict atrial fibrillation recurrence following ablation: The role of systemic immune-inflammation index
Amedeo Tirandi, Federico Carbone, Luca Liberale, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 3
Closed Access
Mitochondrial dysfunction in cardiovascular disease: investigating therapeutic approaches to enhance patient outcomes
Omar Elsaka
MGM Journal of Medical Sciences (2025) Vol. 12, Iss. 1, pp. 127-135
Open Access
The Role of Ferroptosis in Atrial Fibrillation: A Promising Future
Jiabin Zhou, Lingling Qian, Dan Wu, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 4, pp. 127-127
Open Access | Times Cited: 4
What Is the Routine Mitochondrial Health Check-Up Good For? A Holistic Approach in the Framework of 3P Medicine
Olga Golubnitschaja
Advances in predictive, preventive and personalised medicine (2023), pp. 19-44
Closed Access | Times Cited: 10
GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation
Jiani Zhong, Hang Chen, Qiming Liu, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 5, pp. 100917-100917
Open Access | Times Cited: 9
Compartmentalization proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation
Thamali Ayagama, Philip D. Charles, Samuel J. Bose, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109609-109609
Open Access | Times Cited: 3
Desmin variants: Trigger for cardiac arrhythmias?
Wei Su, Stan W. van Wijk, Bianca J.J.M. Brundel
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 15
Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
Antônio da Silva Menezes, Ana Luísa Guedes de França e Silva, Joyce Monteiro de Oliveira, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 535-535
Open Access | Times Cited: 7
Transcriptomic analysis of epicardial adipose tissue reveals the potential crosstalk genes and immune relationship between type 2 diabetes mellitus and atrial fibrillation
Tian-Lun Li, Na‐Na Zhu, Zhao Yin, et al.
Gene (2024) Vol. 920, pp. 148528-148528
Closed Access | Times Cited: 2
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights
Aparajita Sarkar, Kareem Fanous, Isra Marei, et al.
Vascular Health and Risk Management (2024) Vol. Volume 20, pp. 255-288
Open Access | Times Cited: 2
Integrating Evidence of the Traditional Chinese Medicine Collateral Disease Theory in Prevention and Treatment of Cardiovascular Continuum
Iokfai Cheang, Shengen Liao, Qingqing Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
Yuling Jing, Ruixue Yang, Wen Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
The HF-AF ENERGY Trial: Nicotinamide Riboside for the Treatment of Atrial Fibrillation in Heart Failure Patients
Lisa Pool, Paul Knops, Olivier C. Manintveld, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 37, Iss. 6, pp. 1243-1248
Open Access | Times Cited: 10
Cytoskeletal Protein Variants Driving Atrial Fibrillation: Potential Mechanisms of Action
Stan W. van Wijk, Wei Su, Leonoor F. J. M. Wijdeveld, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 416-416
Open Access | Times Cited: 9
Atrial fibrillation

Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 13
Genetically predicted dietary macronutrient intakes and atrial fibrillation risk: a Mendelian randomization study
Zhuoya Zhang, Jiale Zhang, Haoyang Jiao, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment
Justyna Rohun, Danuta Dudzik, Joanna Raczak-Gutknecht, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 34-34
Open Access | Times Cited: 1
Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes
Tuerdi Subati, Zhenjiang Yang, Matthew B. Murphy, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 483-483
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top